Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Carruthers

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal of Medicinal Chemistry|March 18, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonistDevin M Swanson, Adrienne E Dubin, Chandra Shah, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitorsMichael A Letavic, John M Keith, Jill A Jablonowski, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
Journal of Medicinal Chemistry|May 12, 2017
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical CandidateMichael A Letavic, Brad M Savall, Brett D Allison, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical developmentMichael A Letavic, Leah Aluisio, Richard Apodaca, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal of Medicinal Chemistry|March 18, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonistDevin M Swanson, Adrienne E Dubin, Chandra Shah, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitorsMichael A Letavic, John M Keith, Jill A Jablonowski, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
Journal of Medicinal Chemistry|May 12, 2017
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical CandidateMichael A Letavic, Brad M Savall, Brett D Allison, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical developmentMichael A Letavic, Leah Aluisio, Richard Apodaca, et al.
Pageof 10